Exposure to DEET (N,N-diethyl-meta-toluamide) may have influenced the pattern of symptoms observed in soldiers with GWI (Gulf War Illness; Haley and Kurt, 1997). We examined how the addition of DEET (400 mg/kg; 50% topical) to an exposure protocol of permethrin (2.6 mg/kg; topical), chlorpyrifos (CP; 120 mg/kg), and pyridostigmine bromide (PB;13 mg/kg) altered the emergence and pattern of pain signs in an animal model of GWI pain (Nutter et al., 2015) . Rats underwent behavioral testing before, during and after a 4 week exposure: 1) hindlimb pressure withdrawal threshold; 2) ambulation (movement distance and rate); and 3) resting duration. Additional studies were conducted to assess the influence of acute DEET (10-100 μM) on muscle and vascular nociceptor K v 7, K DR , Na v 1.8 and Na v 1.9. We report that a 50% concentration of DEET enhanced the development and persistence of pain-signs. Rats exposed to all 4 compounds exhibited ambulation deficits that appeared 5-12 weeks post-exposure and persisted through weeks 21-24. Rats exposed to only three agents (CP or PB excluded), did not fully develop ambulation deficits. When PB was excluded, rats also developed rest duration pain signs, in addition to ambulation deficits. There was no evidence that physiological doses of DEET acutely modified nociceptor K v 7, K DR , Na v 1.8 or Na v 1.9 activities. Nevertheless, DEET augmented protocols decreased the conductance of K v 7 expressed in vascular nociceptors harvested from chronically exposed rats. We concluded that DEET enhanced the development and persistence of pain behaviors, but the anticholinesterases CP and PB played a determinant role.
Introduction
Chronic pain is a common symptom of Gulf War Illness (GWI) . N 60% of US veterans of the 1991 Persian Gulf War developed a highly varied constellation of deep tissue pains that included headache, muscle, joint, and abdominal pain (Haley and Kurt, 1997; Blanchard et al., 2006; Stimpson et al., 2006; Thomas et al., 2006; Haley et al., 2013) . While GWI typically developed soon after they returned from service in the Persian Gulf, a substantial portion of warfighters reported symptoms while still in theater (~25%; Kroenke et al., 1998) . In the years that followed, the symptoms of GWI tended to remain the same or worsen over time (Hotopf et al., 2003) . After N 20 years of research, there is an emerging consensus that excessive exposure to insecticides and related agents contributed to the development of GWI symptoms (White et al., 2016) . However, the relationship between particular exposure patterns and symptoms has remained elusive.
During their relatively brief deployment, the soldiers of ODS (Operation Desert Storm) were potentially exposed to 64 insecticides and repellants containing 37 distinct active ingredients (U.S. Department of Defense, 2003; Binns et al., 2008 ; Research Advisory Committee on Gulf War Veterans ' Illnesses, 2014) . Our laboratory developed a rat model of Gulf War Illness pain as part of an effort to explore cellular and molecular maladaptations associated with prolonged exposure to insecticides that were employed in ODS. Our early investigations focused on the role of three particular agents that possessed a unique potential to interact with membrane proteins expressed by deep tissue nociceptors. These agents included: 1) permethrin-a type I pyrethroid that was supposed to be applied by soldiers to their uniforms every 4-5 days. Permethrin is a powerful Na v (voltage activated sodium) channel deactivation inhibitor that lengthens action potential duration and thereby permits relatively massive amounts of Ca ++ into intracellular space of nociceptors ; 2) chlorpyrifos-a powerful acetylcholinesterase (AChE) inhibitor with the potential to alter multiple cholinergic signaling mechanisms and pathways that are present in deep tissue nociceptors (Rau et al., 2005; Nutter et al., 2013; Cooper et al., 2016) . Chlorpyrifos was used as an area spray/fogger and was also present in flea collars that soldiers obtained outside of their officially approved panel of agents (Binns et al., 2008) ; and 3) pyridostigmine Toxicology and Applied Pharmacology 316 (2017) [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] bromide (PB)-an acetylcholinesterase inhibitor that soldiers were instructed to use as a prophylactic against potential nerve agent attack (Weinbroum, 2004; Newmark, 2005; Weissman and Raveh, 2011) . PB was supposed to be self-administered by soldiers 3 times per day. Compliance with the prescribed doses and application frequencies of these chemicals was highly variable, and some agents were used excessively (Binns et al., 2008) . Exposing rats to various concentrations and durations of these three GW agents failed to produce a pattern of behavior changes consistent with chronic pain Nutter et al., 2013; Nutter and Cooper, 2014) . We recently found that an intensified exposure to the AChE inhibitors (chlorpyrifos, PB) could produce pain-like behaviors that appeared and/or persisted up to 12 weeks following termination of exposure (Nutter et al., 2015) . Although an 8 week protocol, utilizing an intermittent exposure pattern, and consisting of daily permethrin, chlorpyrifos (twice per month; 7% duty cycle), and PB (14 days per month; 50% duty cycle) could not produce any lasting changes in rat activity levels or superficial pain measurements Nutter and Cooper, 2014) , a doubling of the duty cycle of the anticholinesterases (chlorpyrifos to 14%; PB to 100%), did induce a delayed painlike syndrome that emerged 9-12 weeks after exposure (Nutter et al., 2015) . Using this anticholinesterase intensified protocol, pain-like behaviors were manifested as an increase in resting times and a decrease in free ranging ambulation. Patch clamp studies conducted on dorsal root ganglion neurons harvested from these same rats revealed the development of a variety of cellular and molecular maladaptations to muscarinic receptor (mAChR) signaling pathways and effectors in muscle nociceptors that were consistent with a chronic myalgia (Nutter et al., 2015; Cooper et al., 2016) .
DEET (N,N-Diethyl-meta-toluamide) is an insect repellant that was commonly used by troops during their deployment (Binns et al., 2008) . There is evidence that the application of DEET covaried with the development of pain symptoms in returning veterans (Haley and Kurt, 1997) . DEET has no known direct interaction with the pain system, but has been shown to be a very weak anticholinesterase (Corbel et al., 2009; Wille et al., 2011; Swale et al., 2014) . A recent publication demonstrated that high concentrations of DEET could inhibit both Na v and K v ion channel current amplitudes in rat cortical neurons (Swale et al., 2014 ; see also Corbel et al., 2009) . Our laboratory has associated enhanced Na v 1.9 and decreased K v 7 activity with the appearance of pain-like signs in rats exposed to GW chemicals Nutter et al., 2015; Cooper et al., 2016) . In the experiments described below, we examined the impact of a DEET augmented exposure protocol on the development of pain signs in our rat model. Additional studies clarified the interaction of DEET with nociceptor ion channels implicated in the development of GWI pain.
Methods

Behavioral studies
2.1.1. Subjects. Fifty (50) young adult male rats were used in the pesticide exposure studies (Sprague-Dawley; Envigo/Harlan). An additional 85 rats were used in physiology experiments. Rats entering the study weighed 90-110 g. Terminal weights did not differ significantly in any pesticide exposure group (see Table 1 ). All animals were housed in American Association for Accreditation of Laboratory Animal Care approved quarters, and all procedures were reviewed and approved by the local Institutional Animal Care and Use Committee and ACURO (Animal Care and Use Review Office of the Army Medical Research and Materiel Command). Two rats developed health issues and were euthanized. After chemical exposures had ended, one rat manifested a rigidity of one hindlimb and the second rat developed a ventral midline tumor. There were no signs of acute pesticide toxicity typically associated with permethrin or chlorpyrifos during the execution of these studies.
2.1.2. Chronic exposure protocol. Over a period of 4 weeks, rats (n = 50) were exposed to permethrin (2.6 mg/kg; mixture of 26.4% cis and 71.7% trans; Sigma Aldrich), chlorpyrifos (120 mg/kg; Sigma Aldrich), DEET (200 or 400 mg/kg; Sigma Aldrich) and pyridostigmine bromide (PB; 13 mg/kg; Sigma Aldrich). Permethrin, in ETOH, was applied every day to a shaved area of the back (~1 in.
2 ) between the forelimbs. Chlorpyifos was administered by a subcutaneous injection (corn oil) once every 7 days. The dose of chlorpyrifos was intended to represent a net exposure to the potentially large and varied anticholinesterases that soldiers were exposed to in the Gulf theater (Binns et al., 2008) . Chlorpyrifos was administered in a corn oil formulation that released the agent over a couple of days (Smith et al., 2009) . DEET was administered topically in ethanol at one of two concentrations (25% or 50%). PB was administered daily by oral gavage (tap water) based upon a standard military dose that was adjusted to account for faster pharmacokinetics in rodents (Birtley et al., 1966; Husain et al., 1968; Aquilonius et al., 1980; Breyer-Pfaff et al., 1985) . Rats were weighed once per week throughout the studies and doses were adjusted accordingly. Control rats received only vehicle exposures over the identical time course.
Five distinct groups of rats (n = 10) were formed (see Table 1 ). One group received all 4 agents (Group A). Three groups were exposed to DEET at 50% concentration (400 mg/kg; ETOH) while a fourth group received all 4 agents with DEET reduced to half concentration (Group HD; 200 mg/kg; 25% in ETOH). The latter group served as a positive control for DEET potentiation (Haley and Kurt, 1997) . Two groups received only 3 agents: Group PB (PB excluded) and Group CP (chlorpyrifos excluded). Group C served as a vehicle control group. Agents were always administered in the same order. On the one day per week that rats were dosed with chlorpyrifos, the order was PB, chlorpyrifos, permethrin and then DEET. On the days in which chlorpyrifos was not administered, the order of administration was PB, permethrin and DEET. There was little indication that any combination of chemical exposures affected final body weight (Table 1) .
Assessment of pain behaviors.
Prior to entering the study, rats were acclimated to the behavioral procedures for 2 weeks. Pain assessments were conducted weekly throughout the entire dosing and postdosing periods. A pressure-pain withdrawal threshold was measured using a computer monitored, hand held force transducer (PAM; Ugo Basile). Pressure was applied via a 5 mm diameter ball to the semitendinosus and biceps femoris muscles (left hind limb). During force application, the applied pressure was monitored and instantaneously displayed on a video screen. Video feedback enabled the rate of force application to be regulated by comparison to a standard curve. When the rat withdrew its limb, the force at withdrawal was automatically registered and stored. To complement pressure-pain testing, activity levels (movement distance, average movement rate, and rest time duration) were recorded automatically by infrared sensors in a modified activity box (15 min test period; Fusion Systems, AccuScan Instruments Inc.). The 35 by 40 cm test chamber was modified to prevent rearing behaviors. The chamber was cleaned after each 15 min test period. Behavioral tests were conducted on both chemically exposed (permethrin, chlorpyrifos, DEET, PB) and vehicle treated (ETOH, corn oil, Table 1 The composition of five groups of rats exposed to GW chemicals. Each group was exposed to 3 to 4 agents and/or their respective vehicles. A: All agents; HD: Half DEET; CP: chlorpyrifos excluded; PB: pyridostigmine bromide excluded; C: Vehicles only. (Cardenas et al., 1995; Petruska et al., 2002 Petruska et al., , 2000 ; see also Xu et al., 2010; Ono et al., 2010) . Categorization of cells by 'current signatures' permits relatively simple identification of distinct cell groups with uniform physiological properties and anatomical targets. Categorization procedures have evolved since they were first established by the Scroggs laboratory and subsequently expanded by our laboratory. Using 3 voltage characterization protocols (CP1, CP2 and CP3), we classified small and medium sized neurons as type 5 muscle or type 8 vascular nociceptors. The physiological signature of type 5 nociceptors used in this study included small I H (1.18 ± 0.22 pA/pF; CP1), a high threshold I A (0 mV; CP2) that exhibited a prolonged settling time (55.4 ± 0.87 ms) and a high threshold (N−20 mV; CP3), broad (5.47 ± 0.20 ms at baseline; 0 mV test) Na + current. Type 5 nociceptors were found in both the small and medium sized cell pool (30-45 μM diameter; 80.5 ± 2.92 pF (Petruska et al., 2002 (Petruska et al., , 2000 . Cells not fitting the classification criteria of type 5 or 8 were discarded. Anatomical targets of type 5 and type 8 neurons were determined by a series of anatomic tracing experiments (Jiang et al., 2006; Rau et al., 2007 Rau et al., , 2014 Cooper et al., 2014) . Type 5 and type 8 nociceptors are capsaicin/heat sensitive and co-express vasoactive neuropeptides (substance P and CGRP; Petruska et al., 2002 Petruska et al., , 2000 Rau et al., 2007) .
2.2.3. Isolation of Na v 1.8 and Na v 1.9 channel currents. Following cell classification in Tyrode's solution, Na + currents were isolated in an external solution (Na iso ) containing (in mM): 20 or 70 NaCl, 120 or 70 TEA-Cl, 0.1 CaCl 2 , 0.1 CdCl 2 and 10 HEPES, adjusted to pH 7.4 with TEA-OH. TTX (500 nM) was added prior to the days experiment. Na v 1.9 currents were recorded using the 70 mM Na iso solution while Na v 1.8 currents were recorded using the 20 mM Na iso solution. The pipette solution contained 140 CsF, 10 NaCl, 5 EGTA and 10 HEPES, adjusted to pH 7.4 with CsOH.
2.2.4. Evocation and characterization of Na v 1.9. From a V h of −120 mV, cells were stepped from −80 to −20 mV in 5 mV steps (300 ms duration). Currents were leak corrected, on line, using the P/4 procedure module of Clampex 9.0. DEET or ETOH was applied, by close superfusion (~1 mm), for 2 min prior to testing. All Na v characterizations were performed at room temperature (20°C). Series resistance was corrected 70-80%. Junction offsets were not corrected. Peak currents of non-desensitizing Na v 1.9 were measured 250 ms from the start of the voltage step to avoid contamination by Na v 1.8. The slow desensitizing Na v 1.8 could appear at − 20 mV but it would be fully desensitized within 50 ms of the voltage step. For voltage dependent activation, individual evoked peak currents were transformed into a conductance: G = I peak /(V m − V rev ), where I peak was the test current, V m the test command voltage, and V rev was calculated from the Nernst equation to be 49.6 mV. The conductance was then normalized to the peak conductance (G max ) observed. The voltage dependence of activation was determined from a fit of the voltage-conductance measures to a Boltzmann function of the form: G = G max /(1 + exp.((V .50 − V m )/K)), where V .50 is the voltage at which G is half maximal, and K is a slope factor. Average currents were formed from the normalized peak currents observed over the active range (−65 to −40 mV).
2.2.5. Evocation and characterization of Na v 1.8. Currents were isolated in the Na iso solution as described above. Following a conditioning pulse to −70 mV (1000 ms; V H = −60 mV) a strongly depolarizing step to 0 mV (60 ms), evoked a large amplitude slowly desensitizing inward current. Currents were leak corrected, on line, using the P/4 procedure module of Clampex 9.0. After a stable baseline current was achieved, DEET or ETOH was applied for 9 min by close superfusion. Time dependent changes to the peak Na v 1.8 current were examined over a period of 7 min (2 min following application of DEET/ETOH; 15 s intertrial interval). Peak currents were normalized to cell size (pF). The series resistance was corrected 60-70%. Junction offsets were not corrected. The peak Na v 1.8 current was measured from the peak current to a point (2500 ms) following the voltage step to 0 mV. 2.2.7. Evocation and characterization of K v 7 current. A current subtraction method was used to isolate K v 7 mediated currents from other K + currents that were present as deactivation tail currents. The cell size normalized peak and average K v 7 current was assessed as a conductance to eliminate deactivation voltage confounding of the peak current. For the K v 7 deactivation protocol: a 1000 ms step command to −20 mV was followed by a series of repolarizing 10 mV steps from − 20 to − 90 mV (1000 ms; V H = − 60 mV) followed by a return step to − 60 mV. A tail current could be measured during the repolarization steps. The K v 7 voltage deactivation protocol tests were conducted 3 min following application of the K + isolation solution containing ETOH or DEET. This was followed by application of the K iso solution containing the K v 7 specific antagonist linopirdine (10 μM in ETOH; 3 min application). The K v 7 voltage deactivation protocol was reapplied. The linopirdine sensitive K v 7 current was isolated by subtraction. The amplitude of the linopirdine sensitive tail current was measured from a point beginning 10 ms after the repolarizing voltage step (−30 to − 90 mV) to the point 10 ms prior to the return step to − 60 mV. The currents of individual cells were normalized by cell capacitance (pA/pF) and converted into a conductance (G) as described above, where V rev = − 86.5 mV. A mean G was computed over the range of functional deactivation steps (−30 to −70 mV) to obtain a mean normalized conductance. The peak conductance was determined by inspection.
Evocation and characterization of K DR currents.
For the purpose of this study, the K DR current was defined as the total 4-AP insensitive K + current following removal of the K v 7 component with linopirdine.
The voltage dependent activation of the total K DR current, was assessed, as a tail current, after application of the K v 7 inhibitor linopirdine (10 μM; 8 min). From a holding potential of −60 mV, a 2000 ms conditioning pulse (− 100 mV) was followed by 12 consecutive command steps from −80 to 20 mV (10 mV increments; 500 ms duration). The amplitude of the tail current at −60 mV was measured from the peak relative to the baseline current recorded 2500 ms after repolarization. For each recorded neuron, the amplitude of tail current was normalized to the peak evoked current and then plotted against the activation voltage to obtain a current-voltage relationship. A Boltzmann function was fit and a V .50 determined for each individual cell. The voltage dependence of activation was determined from a fit of the voltage-current measures to a Boltzmann function of the form: I = I max /(1 + exp.((V .50 − V m )/K)), where V .50 is the voltage at which the current (I) is half maximal, and K is a slope factor.
To assess average amplitude, the K DR tail currents, at each voltage, were normalized for cell size (current amplitude (pA) divided by the cell size parameter (pF)). These normalized amplitudes were averaged across functional activation voltages (−60 to 0 mV) to obtain a mean current amplitude.
Statistics
A repeated measures ANOVA was used to assess influence of GW chemical treatments on the development of pain signs (post-exposure weeks 5-12). In order to assess the persistence of pain behaviors, an additional analysis was conducted on the 4 week span proceeding euthanasia (post-exposure weeks 17-20 and/or 21-24, Groups A and C only). Dependent measures included: 1) muscle pain threshold (PAM; grams); 2) ambulation: movement distance (cm/15 min), average movement rate (cm/s); and 3) rest duration (s/15 min). The alpha level was set at 0.05. As noted above, 2 rats were euthanized for health related issues (one rat from Group A and one rat from Group HD). Both were terminated on the advice of the study veterinarian. To equalize the number of animals in each group, the corresponding rat (by date of entry), was excluded from each group. In order to adjust for the high variance, present in rat behavioral data, the means of movement and resting scores were trimmed (highest and lowest scores) prior to construction of plots and performance of analyses (Lix and Keselman, 1998; Wilcox et al., 2000; Mudholkar et al., 2013) .
To determine the influence of DEET on physiology measures, Student's t-tests were used to contrast normalized amplitude, conductance and/or V .50 of Na v 1.8, Na v 1.9, K DR and K v 7 in DEET and vehicle (ETOH) treated cells. The alpha level was set at 0.05.
Results
Behavior
After a period of acclimation and baseline behavioral testing, rats were divided into 5 groups (n = 50). One group (Group A) was treated with all four GWI chemicals for 4 weeks (permethrin 2.6 mg/kg, chlorpyrifos 120 mg/kg, PB 13 mg/kg, DEET, 400 mg/kg; 50% in ETOH). A positive control for the influence of DEET (Group HD) received all 4 agents, but DEET was administered at half the concentration (200 mg/kg; 25% in ETOH). Studies of GW veterans had indicated that skin application of high (75%), but not low concentrations (25%) of DEET, posed a risk factor for chronic pain (Haley and Kurt, 1997) . Our preliminary studies indicated that a 50% level was sufficient to produce enduring pain-like signs. The remaining 2 groups received combinations of 3 agents where either chlorpyrifos (Group CP) or PB (Group PB) was not included in the dosing routine. A final group served as a vehicle treated control (Group C; corn oil, ethanol, water). Details of the dosing schedule are provided in Methods section and Table 1 . Behavior assessment tests were conducted on all rats once per week for 26 weeks (Group PB, Group CP, Group HD) or 30 weeks (Group C, Group A). Tests included muscle pressure withdrawal threshold (PAM; left semitendinosus) and 3 open field activity measures: movement distance (cm), average movement rate (cm/s), and rest time duration (s). All PAM measures were carried out under blinded test conditions. Activity measures were assessed over a period of 15 min, in a 35 × 40 cm Perspex test chamber where movements were monitored and quantified by an automated infrared detection system (AccuScan).
After the 4 week exposure period had ended, we conducted a repeated measures ANOVA on 8 and 4 week blocks that extended from post-exposure week 5 through 24. We had previously reported that rats exposed to the same concentrations of permethrin, chlorpyrifos and PB, but in the absence of DEET, exhibited only paradoxical shifts in movement rate and transient elevations of rest time scores during a 5 to 12 post-exposure assessment (Nutter et al., 2015) . In studies of DEET augmented protocols below, we focused on this 5-12 week post-exposure time period as well as upon test periods extending up to 24 weeks after exposure.
With the addition of DEET (50% in ETOH) to the same 4 week exposure protocol, a consistent pattern of pain-like signs emerged and persisted for up to 6 months (Fig. 1A, B, C) . Both ambulation measures, movement distance and movement rate, were significantly reduced in the immediate weeks following exposure (weeks 5-12; F = 19.47, p b 0.001 and F = 27.71; p b 0.001, respectively). Although the depression of movement distance returned to normal levels by the final assessment period, (weeks 21-24), the slowing of movement rate, due to GWI agents, was still significant 21-24 weeks post-exposure (Fig. 1B) .
While there was a substantial augmentation of ambulation related pain signs when DEET was part of the exposure protocol, there was no evidence that rest durations were similarly affected (Fig. 1C) . We previously reported persistent rest time increases with 8 week exposures to the 3 GW chemicals (chlorpyrifos, permethrin and PB; Nutter et al., 2015; Cooper et al., 2016) , but not with a 4 week exposure to the same agents at identical dosages. As in all our investigations, we also failed to find that these GW agents produced any change in the semitendinosus muscle pressure-pain withdrawal test (PAM; data not shown; Nutter and Cooper, 2014; Nutter et al., 2015; Cooper et al., 2016) . GWI veterans do not report mechanical allodynia to superficial stimuli.
As shown in Fig. 1 , exposure to the 4 agents produced a pattern of activity suppression during the 4 week exposure period that was observed in nearly all experiments below (Figs. 2-4) . Movement distance and average rate were substantially suppressed while resting duration was increased in the presence of DEET, chlorpyrifos, permethrin and PB (F = 62.67, F = 64.16 and F = 10.55 respectively; Fig. 1A , B and C, 'Exposure'). However, the capacity of a given agent or agents to suppress activity scores during exposure was not necessarily related to whether post-exposure pain-like behaviors would occur or persist 5 to 6 months after exposures had ended (see below).
Consistent with reports on symptomatic veterans, high concentrations of DEET were associated with the development GWI pain-like behaviors in rats (Haley and Kurt, 1997) . When the concentration of DEET was reduced to 25% (Group HD; positive control), neither ambulation nor resting measures were shifted in a manner consistent with pain ( Fig. 2A, B and C) . Instead, movement distance and resting scores were paradoxically increased (movement distance) or decreased (resting duration), relative to vehicle treated groups, during the final 4 weeks of testing (post-exposure weeks 17-20). When Group HD was contrasted with Group A (50% DEET), significant pain signs were evident in Group A at both the early phase (5-12 weeks post-exposure) and the late phase of assessment (weeks 17-20; Fig. 2D, E and F) . Interestingly, although no pain-like signs developed with the HD group, we still observed highly significant decreases in ambulation (movement distance and rate), as well as increased rest durations during the exposure period ( Fig. 2A , B and C; F = 48.42, F = 30.45 and F = 5.35, respectively; 'Exposure').
Conditions for the development of GWI pain signs in rats
Given that DEET substantially enhanced the development and persistence of pain-like behaviors, we conducted a series of experiments in order to determine if the development of these behaviors would appear and persist if the anticholinesterases were excluded from the dosing protocol. Our previous report had shown that doubling the anticholinesterase duty cycle had been critical to the development of pain signs in the 8 week protocol. In order to assess the role of AChE inhibitors, we contrasted Groups A and C with groups in which either chlorpyrifos (Group CP) or PB (Group PB) was excluded from the exposure regimen.
3.2.1. The contribution of chlorpyrifos. CP was originally included in the exposure set in order to represent the large variety of anticholinesterase insecticides that warfighters were exposed to during their deployment (Binns et al., 2008) . Statistical analyses comparing vehicle treated rats (Group C) and rats exposed to all agents, except chlorpyrifos (Group CP), confirmed that CP was an essential component of those GW chemicals that induced persistent pain-like behaviors. When CP was omitted from the exposure protocol (Group CP), ambulation deficits were not sustained at post-exposure weeks 17-20 ( Fig. 3A and B) . Although transient shifts in movement rates were present through post exposure weeks 5-12 (Fig. 3B) , movement distance scores also failed to emerge during weeks 5-12 in the absence of CP. When comparisons were made between rats exposed to all 4 agents (Group A) and Group CP, rats that were not exposed to CP exhibited significantly improved ambulation during all phases of the study ( Fig. 3D and E) .
It also appeared that CP contributed significantly to the suppression of movement distance and, to a lesser extent, movement rate that occurred during the 4 week exposure period ( Fig. 3 ; 'Exposure'). As noted above, rats receiving all 4 GWI chemicals typically manifested a substantial reduction of ambulation scores (and elevation of rest times) during the 4 week exposure session (Fig. 1A , B and C; 'Exposure'). In the absence of CP, the suppression of both movement distance and rate were significantly relieved relative to Group A ( Fig. 3D and E ; 'Exposure'; F = 21.99 and F = 42.11). Nonetheless, some weaker suppression of movement rate and induction of resting could still be detected relative to Group C ( Fig. 3B ; 'Exposure'; F = 12.12). 3.2.2. The contribution of pyridostigmine bromide. Exclusion of PB from the chemical exposure protocol substantially altered the development of pain-like behaviors. Like the other anticholinesterase in the exposure set (CP), the inclusion of PB in the 4 week exposure period was necessary for the development of pain signs of movement distance and rate decreases that persisted into weeks 17-20; it was also required for development of these pain behaviors during post-exposure weeks 5-12 (Group PB vs Group C; Fig. 4A and B) . Moreover, in the absence Fig. 2 . Pain-like behaviors did not develop nor persist when DEET concentration was halved. A) Relative to control animals, movement distance was paradoxically increased in during postexposure weeks 17-20 (F = 5.50). B) Average movement rate was unchanged compared to vehicle exposed controls. C) Resting duration was paradoxically decreased relative to control rats in Group HD (weeks 17-20; F = 19.51). There were no indications of pain signs during the early post-exposure period in any measure (weeks 5-12). D and E) When compared to Group A (50% DEET), the reduction of DEET concentration to 25% produced movement distance and rate scores that were significantly higher (more normal) during the last observation period (post-exposure weeks 17-20; F = 12.4, p b 0.001 and F = 17.2, p b 0.001, distance and rate respectively). Pain behaviors appeared during the early testing phase in Group A (F = 16.7 and F = 16.1; p b 0.001, movement distance and rate, respectively). F) At week 17-20, resting was significantly reduced in the 25% DEET concentration group (F = 11.24; p b 0.002), but there were no accompanying shifts during the early post-exposure phase (weeks 5-12). B: baseline testing; A: DEET (400 mg/kg; 50%), PB, chlorpyrifos, permethrin; C/Vehicle: (ethanol, corn oil, ethanol, water); HD: DEET (200 mg/kg; 25%), chlorpyrifos, PB, permethrin; *Significantly different by ANOVA.
of PB, ambulation scores were significantly shifted towards normal levels relative to animals exposed to all 4 compounds (Group PB vs Group A; Fig. 4D and E) .
Unlike CP, the absence of PB from the exposure protocol did not affect movement scores during the exposure protocol (Fig. 4A , B and C, 'Exposure'), and more importantly proved to be permissive for the Fig. 3 . Excluding the AChE inhibitor, Chlorpyrifos, from the exposure protocol prevented development of persistent pain behaviors. A) The omission of CP prevented the suppression of movement (distance) by GW chemicals. B) Average movement rate was still significantly reduced in the early post-exposure phase in the absence of CP (weeks 5-12; F = 6.11). Persistent changes in movement rate did not develop in the absence of CP (post-weeks 17-20). C) Rest durations remained unaffected when CP was absent. D and E) In the absence of chlorpyrifos, movement rate scores were shifted significantly towards vehicle exposure levels relative to groups that were exposed to all 4 agents. Significant rescue was observed over post-exposure weeks 5-12 (rate: F = 4.37) and 17-20 (F = 4.67 and F = 7.84, movement distance and rate respectively). F) The exclusion of CP shifted resting scores toward vehicle levels only during the period of exposure (F = 42.11). No other shifts were observed relative to Group A rats. B: baseline testing; A: DEET, chlorpyrifos, PB, permethrin; C: (ethanol, corn oil, ethanol, water); CP: DEET, PB, permethrin. *Significantly different by ANOVA. development and persistence of resting pain signs over the course of post-exposure testing. Rats that did not receive PB treatment developed significant and substantial increases in resting behaviors over weeks 5-12 (Group C vs Group PB). These behaviors persisted into weeks 17-20 (Fig. 4C) . Moreover, when Group PB resting times were compared to Group A, scores were not shifted toward normal levels. Instead, resting pain signs were further increased relative to the group that received all 4 agents (Fig. 4E) . Therefore, the contribution of PB was to exert a Fig. 4 . Excluding pyridostigmine bromide from the exposure protocol differentially contributed to the development and persistence of pain behaviors. A) Movement distance was unaffected in the absence of PB. B) Except for a paradoxical increase in weeks 17-20 (F = 5.05), the average movement rate was also unaffected by GWI chemicals when PB was excluded from the exposure set. C) In the absence of PB, significant increases in rest duration scores emerged during the early post-exposure phase (weeks 5-12; F = 11.60) and persisted into the final month of measurement (post-weeks 17-20; F = 7.27). D and E) In the absence of PB, final movement distance and rate scores were shifted significantly towards vehicle exposure levels relative to groups that were exposed to all 4 agents (weeks 17-20: F = 6.04 and F = 17.34, movement distance and rate respectively). Movement distance and rate scores were also rescued during the early post-exposure phase (weeks 5-12: F = 4.00 and F = 23.69, respectively). F) The exclusion of PB accentuated the influence of the remaining 3 GW chemical on rest durations during both post-exposure assessment periods (weeks 5-12: F = 18.49; weeks 17-20; F = 6.19). B: baseline testing; A: DEET, chlorpyrifos, PB, permethrin; C: (ethanol, corn oil, ethanol, water); PB: DEET, chlorpyrifos, permethrin. *Significantly different by ANOVA.
protective influence against the development of pain associated with increased resting. Given that PB was prescribed to soldiers as a prophylactic against nerve agent anticholinesterases (i.e., Soman/Sarin), it is not surprising that such a finding could emerge. However, it is not a simple matter to reconcile this finding with the influence on movement distance and rate, in which PB contributed to impairments over the entire post-treatment period.
The influence of DEET on K v and Na v ion channel physiology
Our previous studies indicated that an 8 week exposure to 3 GWI chemicals (chlorpyrifos, permethrin and PB) increased rest time durations and lowered movement distance scores 9-12 weeks post-exposure. Patch clamp physiology performed on cells harvested from those rats revealed that muscle nociceptors exhibited decreased net activity of K v 7 and other K DR ion channels (Nutter et al., 2015) . We further demonstrated that muscle nociceptors manifested a unique action potential burst discharge in response to activation of muscarinic receptors (mAChR); and that these action potential bursts were modulated by K v 7 and potentiated in rats exposed to the GWI chemicals (Nutter et al., 2015) . The low voltage activated K + channel, K v 7, is known to be important for governing neuronal excitability (Brown and Passmore, 2009) .
As the inclusion of DEET in the exposure protocol intensified and shifted the pattern of behavioral outcomes, we hypothesized that DEET might also influence the activity of K v (and other ion channels) channels that have been associated with the development of painsigns in rats (K DR ). It was recently shown that DEET (~100 μM) significantly diminished the amplitude of the K DR in cultured rat cortical neurons (Swale et al., 2014) . Therefore, we initiated a series of studies which examined the influences of DEET on nociceptor K v 7 ion channels and the residual K DR (that K DR remaining after K v 7 and 4-AP sensitive channels were removed). Studies were focused on muscle nociceptors as these were the class of neurons that had been shown to be modified by GW agent protocols that produced persistent pain-like behaviors in our rat model (Nutter et al., 2015; Cooper et al., 2016) .
3.3.1. The influence of DEET on nociceptor K v 7 and K DR .
Young adult male rats served as subjects. Cells were harvested and plated on the morning of the experiment, and discarded afterwards. Recordings began approximately 2 h after plating. Neurons identified as muscle or vascular nociceptors were exposed to DEET (10 or 50 μM). K v channels were isolated from other voltage activated currents using a K iso solution described in Methods section. In control cases, equal volumes of vehicle (ethanol/ETOH) were substituted for DEET. In the case of K DR , Boltzmann functions were used to describe the voltage dependent data. Individual cases in which Boltzmann functions could not be fit to K DR currents were excluded from the analysis.
As shown in Fig. 5 , we were unable to detect any influence of DEET (10-50 μM) on voltage dependence or amplitude of either K v 7 or K DR ion channels expressed in muscle nociceptors. There were no influences of DEET on average (Fig. 5A ) or peak conductance (not shown) of K v 7. Nor were changes observed in the calculated V .50 or average currents evoked from K DR channels ( Fig. 5B and C) . Accordingly, the amplification of behavioral pain signs exhibited 5-24 weeks after DEET exposure, could not be attributed to a direct influence of DEET on K v channels during the exposure.
3.3.2. The influence of DEET on nociceptor Na v . Acute exposure to pyrethroid insecticides, such as permethrin, have powerful influences on the properties of TTX sensitive (Na v 1.6, Na v 1.7) and TTX insensitive (Na v 1.8) ion channels expressed in DRG (Ginsburg and Narahashi, 1993; Tatebayashi and Narahashi, 1994; Tabarean and Narahashi, 1998; Tabarean and Narahashi, 2001; Jiang et al., 2013) . Na v 1.8 is expressed in a high proportion of nociceptors and is the principle Na v that forms action potentials in these neurons (Djouhri et al., 2003; Jiang and Cooper, 2011) .
Prolonged exposure to permethrin, chlorpyrifos and PB changes inactivation characteristics of Na v 1.8 and prolongs action potential duration (Nutter et al., , 2015 Nutter and Cooper, 2014) . Given that high concentrations of DEET (N500 μM) were recently shown to reduce the amplitude of mixed cortical Na v , we examined whether such effects could be identified in DRG nociceptors at levels which might be physiologically significant (Swale et al., 2014) .
3.3.3. The influence of DEET on Na v 1.8. Cells were plated as described above. Following identification of a neuron as a muscle or vascular nociceptor, TTX insensitive Na v were isolated from other voltage activated currents using the Na iso solution ([Na + ] = 20 mM) and 500 nM TTX (described in Methods section). Time dependent changes to Na v 1.8, in the presence of DEET, were examined. Following a conditioning pulse to −70 mV a strongly depolarizing step to 0 mV (60 ms), evoked powerful inward currents (Fig. 6A insert) . In the presence of vehicle (ETOH), a stable peak current was established over 6-10 evocations (pre-test series). Subsequently, DEET containing solutions were presented for 2 min by close superfusion (100 μM) and the protocol was then restarted and continued for 7 additional minutes in the continuous presence of DEET (post-test series; 15 s intervals; 28 total tests). In separate experiments, pre and post-test solutions contained only ETOH vehicle.
We compared the percentage change in leak corrected peak amplitudes of Na v 1.8 between ETOH baseline and DEET treated cases (post/ pre). We found no evidence that a 9 min presentation of 100 μM DEET could reduce the amplitude of Na v 1.8 in either muscle or vascular nociceptors (Fig. 6 ).
3.3.4. The influence of DEET on Na v 1.9. Following an 8 week exposure to three GWI chemicals, the amplitude of TTX insensitive , Na v 1.9 was significantly increased . Although Na v 1.9 does not contribute to the formation of action potentials (Cummins et al., 1999; Dib-Hajj et al., 2002) , it is an important contributor to nociceptor discharge properties (Fang et al., 2002; Jiang and Cooper, 2011) . Due to its ultraslow kinetics and hyperpolarized voltage dependence, Na v 1.9 could mediate burst discharges via the formation of long duration 'plateau' potentials (Copel et al., 2009 , Herzog et al., 2001 Maingret et al., 2008) . If DEET influenced the amplitude of Na v 1.9 during exposure, it might amplify the post-exposure influence of GWI chemicals (permethrin, chlorpyrifos and PB) on the physiology of Na v 1.9. Accordingly, we examined whether an acute presentation of DEET would modify this unique TTX insensitive Na v channel.
Muscle and vascular nociceptors were isolated as described above. A Na iso solution ([Na + ] = 70 mM; 500 nM TTX; see Methods section) containing either DEET or vehicle (ETOH) was applied for 2 min. After this conditioning period, a family of voltage dependent currents were generated using stepped pulses from −80 to −20 mV (V H = −120 mV, 5 mV steps, 300 ms duration). Leak corrections were performed on line and activation curves were constructed by fitting a Boltzmann function. Individual cases in which Boltzmann functions could not be fit were excluded from the analysis.
DEET exhibited some weak and inconsistent influences on Na v 1.9. Following application of DEET to muscle and vascular nociceptor Na v 1.9, there was some indication that high doses (N100 μM) might modulate the current. When the averaged peak amplitudes of the DEET treated currents were compared to vehicle treated cases, it appeared that trends favored a decrease in amplitude at doses exceeding 100 μM. All comparisons to vehicle treated cases were non-significant; however, a significant difference was observed between tests at 50 and 100 μM (Fig. 7C) . In addition to the averaged current, we observed a significant~− 2 mV shift in the voltage dependence of muscle nociceptor Na v 1.9 (V .50 ; 50 μM; Fig. 7A ). However, we could not reproduce the voltage shift at 100 μM DEET. No effects of DEET were observed for voltage dependence of vascular nociceptor Na v 1.9 (Fig. 7A and B) . As these shifts all occurred at what were clearly non-physiological doses, we did not pursue these trends any further.
Nociceptor physiology in rats chronically exposed to combinations of DEET, permethrin, PB and chlorpyrifos
We examined whether the, DEET augmented, 4 week exposure protocol altered nociceptor physiology. Experiments were conducted on Group A, Group PB and Group C rats. Twelve weeks after exposures ended, DRGs were excised from rats for whole cell patch clamp studies. Recordings were obtained from vascular nociceptor (type 8) K v 7 ion channels using solutions and protocols described in Methods section.
As shown in Fig. 8 , the conductance of nociceptor K v 7 ion channels harvested from Group A and Group PB rats exhibited decreased activity relative to vehicle exposed controls. Although distinct exposure protocols led to distinct behavioral outcomes (Figs. 1 and 4) , there were no differences in K v 7 activity in neurons harvested from Group A versus Group PB (Fig. 8A and B) .
Discussion
We previously identified a protocol in which an 8 week, but not a 4 week, exposure to 3 GWI agents (chlorpyrifos, permethrin, PB) produced a pattern of behavior that could be interpreted as a delayed chronic pain syndrome that resembled a subset of symptoms that afflicted veterans following their return from the 1991 Persian Gulf War Nutter et al., 2015) . A key factor leading to the development of those pain-like behaviors was a doubling of the Fig. 6 . Time dependent modification of Na v 1.8 by DEET. A) The amplitude of muscle nociceptor Na v 1.8 was not changed by DEET (100 μM). A representative Nav1.8 current is inserted. B) Vascular nociceptor Na v 1.8 amplitude was not altered by DEET (100 μM). Baseline records were taken prior to DEET or ETOH exposure. The average of the last three pre-tests was used as a baseline score. DEET was pre-applied for 2 min prior to 7 min of continuous post-test recording (15 s test intervals). This data was collected from 19 rats.
anticholinesterase duty cycle from 7% (twice per month) and 50% (15 times per month) to 14% and 100% (chlorpyrifos, PB; respectively). Given that DEET usage has been statistically associated with the development of the GWI pain syndrome (syndrome 3; Haley and Kurt, 1997), we examined whether the addition of this repellant to our exposure protocol would promote the appearance of pain behaviors in our rat model. Our studies have now shown that DEET hastened the development and extended the persistence of pain-like behaviors that appeared following a 4 week exposure to chlorpyrifos, permethrin and PB. Relative to either vehicle or positive control groups, rat ambulatory behaviors were suppressed as early as 5-12 weeks post-exposure and remained suppressed out to the 17-24 week test periods. These behavior shifts were accompanied by a decreased conductance in vascular nociceptor K v 7. Despite the powerful influence of DEET, the development and persistence of pain signs were shown to be mainly dependent, albeit in a complex fashion, on the anticholinesterase components of the exposure protocol.
Experiments in which chlorpyrifos or PB were eliminated from the exposure set gave clear indications of the importance of these anticholinesterases for the development and maintenance of pain behaviors. In the absence of CP, ambulation deficits were substantially reduced or prevented. Although the removal of PB had much less impact on behavior patterns occurring during the exposure, the extent of reversals of post-exposure ambulation measures were even more complete in the absence of PB.
DEET potentiates the development of a chronic pain condition
Despite the critical contribution of the anticholinesterases to the development of pain signs in our model, the fact that any ambulatory deficits appeared, following a 4 week exposure, seemed to be attributable to the inclusion of DEET in the exposure set. When the concentration level of DEET was halved from 50 to 25%, there was no indication that DEET potentiated or altered the pattern of pain signs. This finding is consistent with the observation that veterans that applied a 75%, but not a 25% concentration of a commercial DEET preparation were more likely to develop GW pain symptoms (Haley and Kurt, 1997) . The means by which DEET amplified the impact of GW chemicals remains uncertain, but it is unlikely to be due to its weak anticholinesterase activity (Corbel et al., 2009; Wille et al., 2011; Swale et al., 2014) .
We had reported previously that exposure to chlorpyrifos, permethrin and PB, sufficient to produce ambulatory and resting pain signs, was accompanied by diminished conductance through muscle, but not vascular, nociceptor, K v 7, ion channels (Nutter et al., 2015) . As a voltage Fig. 7 . Voltage activated, Na v 1.9, channels were weakly modulated by acute exposure to DEET. A) The voltage dependent activation of muscle nociceptors was hyperpolarized at 50 but not at 100 μM DEET. A representative trace of a Na v 1.9 current (step to −50 mV; V H = −120 mV) is included as an insert. B) The voltage dependent activation of vascular nociceptors was unaffected by DEET. C) Average currents of muscle nociceptors were unaffected by DEET (p b 0.13, Vehicle vs 100 μM; p b 0.05, 50 vs 100 μM); D) Vascular nociceptor average currents were unchanged (p b 0.17, Vehicle vs 100 μM; p b 0.08, 50 vs 100 μM). The voltage-activation curves were formed from the mean conductances of all cells averaged at a given voltage. Statistical tests were performed on V 50 's computed from individual curve fits. Average currents were determined as the mean, cell size normalized, current over the activation range (−65 to −40 mV). **Significantly different from vehicle treated cases; + significantly different from 50 μM tests. Thirty-two rats contributed to these graphs. dependent brake on membrane potential, a reduction in K v 7 activity increases neuronal excitability (Brown and Passmore, 2009 ). Moreover, we have recently demonstrated muscarinic agonist induced, K v 7 modulated, action potential bursts in muscle nociceptors of GW agent exposed rats (Nutter et al., 2015; Cooper et al., 2016) . In the DEET augmented protocol, we again report decreased conductance of K v 7 channels, but they are now manifested in vascular nociceptors. Potentially, an expanded impact on vascular nociceptor populations, in the presence of DEET, altered the development and pattern of behavioral outcomes. The removal of PB from the exposure protocol also shifted the pattern of behavioral signs, but there was no indication that this was reflected, in any way, by K v 7 activity. The decline in K v 7 activity was not influenced by the presence or absence of PB.
While DEET clearly potentiated behavioral maladaptations, and may have potentiated shifts in vascular nociceptor physiology, we could not demonstrate any acute influences of DEET on K v 7 activity. Nor did we observe acute influences, by DEET, on other ion channels that have been implicated in GWI agent-induced maladaptations (i.e., Na v 1.8, Na v 1.9 and K DR ; Nutter and Cooper, 2014; Nutter et al., 2015; Cooper et al., 2016) . The absence of effects of DEET on known and suspected GW agent maladapted ion channel proteins does not preclude a direct molecular level interaction of DEET with deep tissue nociceptors through other pathways; nor does it rule out an indirect interaction through secondary pathways yet to be identified.
Chlorpyrifos is an AChE inhibitor, but one of its hepatic metabolites, chlorpyrifos-oxon is 1000 fold more potent in that role (Huff et al., 1994) . In a direct assessment of the hepatic interaction of these to GW agents, Usmani and colleagues reported that DEET increased the hepatic conversion of chlorpyrifos to its oxon form by a factor of 2.4 (Usmani et al., 2002) . Potentially the amplification of pain signs, by DEET, occurs through its capacity to increase the peak levels of the more potent oxon form of CP (Abou-Donia et al., 1996; Abu-Qare and Abou-Donia, 2008) . Moreover, it has been shown that co-administration of PB with DEET, slows hepatic DEET metabolism, and as a result could further enhance the DEET potentiated conversion of chlorpyrifos to chlorpyrifosoxon (Abu-Qare and Abou-Donia, 2008; see also Chaney et al., 2000) . Therefore, the amplification of pain signs by addition of DEET, in an otherwise ineffective protocol, could simply be due to an increase in the effective peak concentration of chlorpyrifos-oxon. Just as increasing the duty cycle of the anticholinesterases potentiated pain signs with an 8 week exposure (Nutter et al., 2015) , increasing the functional concentration of chlorpyrifos-oxon, during a 4 week exposure, could have potentiated and prolonged ambulatory deficits.
It is well known that single high dose exposures to certain organophosphate anticholinesterases have been linked to the development of a progressive motor and sensory neurodegenerative disorder known as OPIDN/OPIDP (organosphophate induced delayed neuropathy/ polyneuropathy; Johnson, 1975; Vale and Lotti, 2015) . One to three weeks after a single exposure, subjects develop a variety of symptoms that include progressive ataxia, paresthesias, and muscle pain. These are accompanied by a peripheral axonopathy characterized by slowed action potential conduction and evidence of Wallerian degeneration (Lotti and Moretto, 2005) . Most animal studies have been conducted on 'susceptible' species (chickens and mice). Severe inhibition of NTE (neuropathy target esterase) and induction of intracellular, phosphorylation pathways are key events leading to the development of the axonopathy associated with OPIDN (Abou-Donia and Lapadula, 1990; Pope et al., 2005; Choudhary et al., 2006; Emerick et al., 2012) . However, rats are considered to be highly resistant to OPIDN (but see Padilla and Veronesi, 1988; Moretto et al., 1992; Choudhary et al., 2001) , and there is little evidence that chickens, mice or rats, develop classic signs of OPIDN following single or multiple exposures to either chlorpyrifos or PB (Richardson, 1995; Lotti, 2002a; Wilson et al., 2002; Kropp and Richardson, 2003; Wang et al., 2014) . Although sequential exposure to some organophosphates (including chlorpyrifos) with certain 'nonneuropathic' NTE inhibitors potentiates organophosphate inhibition of NTE and ultimately leads to the development of OPIDN (Pope and Padilla, 1990; Pope et al., 1993; Lotti et al., 1991; Lotti, 2002b) , we cannot point to any specific evidence linking PB, permethrin or DEET to promotion of a chlorpyrifos dependent OPIDN.
Complex influences of chlorpyrifos and PB on pain signs
The evidence that linked the anticholinesterases to the development of ambulation deficits was relatively straightforward. The contributions of CP and PB were internally consistent on these measures: exclusion of either CP or PB blocked the development of ambulation pain-signs and significantly shifted ambulation scores that accompanied 4 agent exposures, toward normal levels. The exclusion of PB was more definitive in this regard, as its presence was required for the development of both movement distance and rate impairments (weeks 5-12). However, both the anticholinesterases were required for the persistence of ambulation deficits out to 20 weeks post-exposure. Unexpectedly, we observed that the development of rest duration pain signs diverged from those of ambulation. Resting increased during the post-exposure Fig. 8 . The conductance of K v 7 ion channels was reduced in vascular nociceptors of exposed rats. A) The average conductance (−30 to −70 mV) was significantly reduced in both Group A and Group PB nociceptors. B) The peak conductance was significantly reduced only in cells harvested from rats that were not exposed to PB during the 4 week period. GRP A: PB, permethrin, chlorpyrifos and DEET; GRP PB: permethrin, chlorpyrifos and DEET VEH: water, ETOH, corn oil, ETOH. The insert in panel 'A' is a schematic representation of the voltage protocol test sequence. Cells were depolarized to −20 mV for 1000 ms and repolarized (−30 to −90 mv) for 1000 ms. The linopirdine sensitive current was determined by subtraction. Eighteen rats contributed to this experiment. **Significantly different from vehicle exposed cases.
phase only in the absence of PB. Moreover, resting pain signs were further increased relative to groups receiving all four chemicals. The divergent influence of the two anticholinesterases on rat activity measures must be considered, not only with respect to their interactive anticholinesterase activity, but also in the broader context of their non-cholinesterase interactions with the nervous system. PB, a reversible inhibitor of AChE, was approved for use in ODS due to its capacity to act as a prophylactic, and when combined with antidotes (2-PAM; atropine) to reduce the lethality of highly potent and irreversible anticholinesterase nerve agents such as Soman (Maxwell et al., 1988; von Bredow et al., 1991; Koplovitz and Stewart, 1994; Kassa and Fusek, 1998; Weinbroum, 2004; Newmark, 2005; Weissman and Raveh, 2011) . Chlorpyrifos-oxon is an irreversible anticholinesterase whose anticholinesterase activity is significantly reduced by pre-treatment with PB (Henderson et al., 2012) . When PB was left out of our dosing protocol, the loss of this prophylactic action might be manifested in the development of resting pain signs. In partial support of this, we have shown that increasing the duration of exposure to CP to 8 weeks, also increases resting scores in weeks 9-12 (Nutter et al., 2015; Cooper et al., 2016) .
While PB has a demonstrated capacity to oppose the anticholinesterase effects of chlorpyrifos-oxon (Henderson et al., 2012) , it has no capacity to oppose or prevent the extra-anticholinesterase effects of chlorpyrifos-oxon. The latter are considerable and well documented. Independent of any inhibition of AChE, chlopryrifos-oxon, as well as some other organophosphates used in the Gulf War (i.e., malathion/maloxon) can directly bind to, activate, and cause internalization of muscarinic receptors (Ward et al., 1993; Huff et al., 1994; Ward and Mundy, 1996; Bomser and Casida, 2001; Olivier et al., 2001; Howard and Pope, 2002; Liu et al., 2002; Zou et al., 2006; Mirajkar and Pope, 2008; Udarbe Zamora et al., 2008 ; see also Smulders et al., 2004) . Chlorpyrifos-oxon also modulates the activity of a variety of G-protein coupled protein kinases and receptor protein kinases (Huff and Abou-Donia, 1995; Huff et al., 2001; Bomser and Casida, 2000; Bomser et al., 2002; Zhang et al., 2002; Torres-Altoro et al., 2011; Suriyo et al., 2015) . Repeated exposure to chlorpyrifos ultimately alters the expression of muscarinic receptors in the CNS (Nostrandt et al., 1997; Liu et al., 1999; Huff et al., 2001; Abou-Donia et al., 2003; Zhang et al., 2002; Padilla et al., 2005; Pung et al., 2006; Proskocil et al., 2010) and modifies the functional consequences of mAChR activation in PNS nociceptors (Nutter et al., 2015; Cooper et al., 2016) .
How these multiple cholinesterase and non-cholinesterase actions contribute to the development of specific pain signs cannot be readily resolved in this report. Our examination of vascular nociceptor K v 7 did not reveal any differential influences attributable to the presence or absence of PB in the exposure protocol (see above). Soldiers suffering from GWI pain describe highly diverse symptom patterns (i.e., muscle pain, back pain, joint pain, abdominal pain, headache) that suggest pathology in multiple, functionally distinct, nociceptor pools that innervate these diverse tissues (Blanchard et al., 2006; Stimpson et al., 2006; Thomas et al., 2006; Haley et al., 2013) . In the absence of PB, additional nociceptive pools, under the full influence of both the anticholinesterase and extra-cholinesterase actions of CP, could suffer significant maladaptations that are manifested as distinct forms of pain.
Summary and conclusions
DEET substantially potentiated and prolonged the pain signs that developed after a 4 week exposure to GW agents. The pattern of pain signs associated with a DEET augmented exposure set diverged from those observed after an 8 week exposure to the same GW agents in the absence of DEET (Nutter et al., 2015; Cooper et al., 2016) . While we were unable to identify a specific linkage between nociceptor ion channel physiology and acute exposure to DEET, such interactions may yet be found. At present, it is more likely that DEET indirectly amplifies the physiological impact of chlorpyrifos on a variety of molecular targets.
Soldiers deployed to the Persian Gulf were potentially exposed to a large variety of insecticides, repellants, nerve agents, adjuvants, depleted uranium, and other toxins (Binns et al., 2008 ; Research Advisory Committee on Gulf War Veterans' Illnesses, 2014). A high percentage developed symptoms while still in theater (~25%; Kroenke et al., 1998) , but most developed a wide variety of pain symptoms that were delayed in onset and worsened over time (Hotopf et al., 2003) . The variations of the symptoms, as well as the timing of their onset, could represent different exposure patterns (and degrees of exposures) and how they ultimately interacted with the genetic makeup of each individual. Acknowledging that, it is likely that there were common risk factors that set into motion a definable set of maladaptations that resulted in the symptoms of GWI. Most of our research points to the fundamental role of the anticholinesterases, CP and PB, as primary risk factors for pain. Although it is not clear that it was specifically their anticholinesterase activity that posed the greatest risk, the manifestations of pain-like behaviors appeared after doubling the exposure duty cycle of PB and CP (Nutter et al., 2015; Cooper et al., 2016) . Adding DEET to the exposure set accelerated the development, altered the pattern and prolonged the persistence of pain-like behaviors that were ultimately dependent upon the presence of chlorpyrifos and/or pyridostigmine bromide. The impact of DEET augmentation on vascular nociceptor K v 7 physiology might account for some of the resultant behavioral signs, but could not account for the differential influences of PB on these signs.
PB was prescribed to soldiers to protect them from nerve agents such as Soman or Tabun (Gordon et al., 1978; Gall, 1981; Ray et al., 1991; Adler et al., 1992; Kassa and Vachek, 2002; Kassa and Krejeova, 2003; Maselli et al., 2011 ; but see Shiloff and Clement, 1986) . The full benefit of PB pre-treatment required timely administration of antidotes, such as 2-PAM and atropine (Maxwell et al., 1988; von Bredow et al., 1991; Adler et al., 1992; Koplovitz and Stewart, 1994; Kassa and Fusek, 1998; Kassa and Vachek, 2002; Layish et al., 2005) . Ironically, Soman was never encountered in the Persian Gulf; and while Sarin nerve agent was encountered, PB had not been shown to be a useful prophylactic against Sarin (Koplovitz et al., 1992; Worek and Szinicz, 1995; Wilson et al., 2002 ; but see Tuovinen et al., 1999) . As this could not be known beforehand, measures were taken that were believed to offer the best margins of safety for the warfighters. Probably half of the soldiers deployed to the Persian Gulf self-administered PB, without antidote, for several weeks. The antidotes were not to be taken unless there was an indication that a nerve gas attack was imminent or in progress (Binns et al., 2008) . Accordingly, soldiers took PB routinely in anticipation of attacks that rarely, if ever, materialized and for which its prophylactic action was documented to be of little use. As a result, they may have been self-administering an agent that accentuated the toxic effects of insecticides and repellants through an hepatic overload (Abou-Donia et al., 1996) . Nevertheless, as the present data indicates, routine administration of PB did afford a degree of protection against the physiological impact of some of the anticholinesterase insecticides to which the soldiers were overexposed, and whose toxicity was amplified by what was thought to be a harmless repellant (DEET). Yet, PB could not protect them from, and may have actually amplified the actions of, the oxon metabolites of the organophosphates that asserted their deleterious actions through pathways that were independent of anticholinesterase activity but had the capacity to derange important components of the nervous system.
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